Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE

Abstract Background The noninterventional XALIA study compared rivaroxaban with standard anticoagulation for deep vein thrombosis treatment. This substudy describes the demographics, clinical characteristics, and outcomes of the patients with cancer. Methods Therapy type, d...

Full description

Bibliographic Details
Main Authors: Walter Ageno, Lorenzo G. Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Alexander G. G. Turpie
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2017-06-01
Series:TH Open
Subjects:
cancer-associated thrombosis
low-molecular-weight heparin
rivaroxaban
routine clinical practice
venous thromboembolism
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1603924

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1603924

Similar Items